NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/05/2026
Voltar para busca
Dado oficial do USPTO
ABCELY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ABCELY
ST13
US500000079396077Classe
1, 5, 42, 44
Pedido
79396077
Registro
8258087
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
19/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
20/03/2024
Data de registro
19/05/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/05/2026
Última transação
19/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
34
Localização do titular
FR
Examinador
MESSICK, TABITHA LEE
Unidade examinadora
L40
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
ABCELY
Representantes
Steven J. Solomon Tucker Ellis LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and science; chemicals for use in industryspecifically for biotechnological product development; chemical additives used in the manufacture of medicines or other active chemical ingredients; chemical and biological preparations for use in industry and science; none of the aforementioned products relating to the veterinary field and animal health.
Classe 5
Pharmaceutical preparations for treatment of cancerslung cancercolorectal cancerstomach canceresophageal cancercervical cancerbreast cancerpancreatic cancerprostate cancer; sanitary preparations for medical use; chemical and biological preparations for pharmaceutical use for the treatment of cancerslung cancercolorectal cancerstomach canceresophageal cancercervical cancerbreast cancerpancreatic cancerprostate cancer; biological reagents for medical purposes; radioactive pharmaceutical preparations for use in in vivo diagnostics; pharmaceutical preparations for medical usespecifically for the treatment of cancers namelylung cancercolorectal cancerstomach canceresophageal cancercervical cancerbreast cancerpancreatic cancerprostate cancer; biological preparations for diagnosis of cancerslung cancercolorectal cancerstomach canceresophageal cancercervical cancerbreast cancerpancreatic cancerprostate cancer; biological and pharmaceutical preparations for the prevention and treatment of cancer; human immunoglobulin being pharmaceutical preparations for the treatment of cancerinflammatory and infectious diseases; none of the aforementioned products relating to the veterinary field and animal health.
Classe 42
Biotechnology research; biological researchclinical research in the field of cancerinflammatory and infectious diseases; medical research; medical research laboratory services; none of the aforementioned services relating to the veterinary field and animal health.
Classe 44
Collection and preservation of human biological tissueblood and cells; medical diagnostic services; medical treatment services; medical testing for diagnostic or treatment purposes; medical analysis services for the diagnosis and treatment of persons; analysis and treatment of blood plasma and stem cells being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing information and data for medical diagnosis and treatment; providing information in the field of cancer preventionscreeningdiagnosis and treatment; none of the aforementioned services relating to the veterinary field and animal health
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
19/05/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/03/2026
PUBO
PUBLISHED FOR OPPOSITION
31/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/03/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/03/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
05/03/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/03/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
05/03/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/03/2026
DOCK
ASSIGNED TO EXAMINER
26/02/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/11/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/10/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
22/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/08/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/08/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
14/08/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
28/06/2025
GNFR
FINAL REFUSAL E-MAILED
28/06/2025
CNFR
FINAL REFUSAL WRITTEN
28/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/03/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/03/2025
RFNT
REFUSAL PROCESSED BY IB
19/10/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/10/2024
RFRR
REFUSAL PROCESSED BY MPU
02/10/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/09/2024
CNRT
NON-FINAL ACTION WRITTEN
28/09/2024
DOCK
ASSIGNED TO EXAMINER
27/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
29/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/05/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/05/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ABCELY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.